Overview of the Migraine Drugs MarketThe global Migraine Drugs Market is valued at $6.37 billion in 2024 and is projected to ...

Revenue of $168 million, meanwhile, came in modestly above expectations of $167 million and up from $167 million in the prior-year period. However, its GAAP gross margin declined significantly to 23.2 ...

The "Biotechnology for the Non-Biotechnologist Training Course" conference has been added to ResearchAndMarkets.com's offering. The importance of the biotech industry has increased significantly over ...

The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the ...

The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...

Rapid tests could be used to diagnose Chagas disease in resource-limited areas, according to a study led by the Barcelona ...

The report covers profiles of key global players including Thermo Fisher Scientific, Sartorius , Danaher, Merck KGaA, Saint-Gobain Life Sciences, Pall Corporation, GE Healthcare (Cytiva), Lonza Group, ...

KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present ...

This important study explores the conserved role of IgM in both systemic and mucosal antiviral immunity in teleosts, challenging established views on the differential roles of IgT and IgM. The ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...